About The Mounjaro
What is Mounjaro
Mounjaro is the brand name for tirzepatide, a prescription medication made by Eli Lilly. It is approved by the U.S. FDA to treat type 2 diabetes, and it's also gaining wide attention for its strong weight loss effects, even in people without diabetes. Mounjaro is a dual GIP and GLP-1 receptor agonist. That means it mimics two natural hormones in your body — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones help:
- Control blood sugar levels
- Slow digestion
- Reduce appetite
- Increase insulin when needed
- Make you feel full longer
Common Uses:
- FDA-approved: To improve blood sugar in adults with type 2 diabetes
- Off-label: Often prescribed for weight loss, even in non-diabetics
Mounjaro for Weight Loss:
In clinical trials, some people lost 15–25% of their body weight when using Mounjaro, especially when combined with a healthy diet and exercise. It’s seen as one of the most effective weight loss injections currently available.
How It’s Taken:
- Form: Once-weekly injection (under the skin)
- Dosage: Starts low and is gradually increased to reduce side effects
Possible Side Effects:
Nausea
- Vomiting
- Diarrhea or constipation
- Fatigue
In rare cases: pancreatitis, gallbladder issues, or thyroid tumors
Important Notes:
- Not for type 1 diabetes or children
- Should be used under medical supervision
- Works best when combined with lifestyle changes
